SynOx Therapeutics
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $119M
Investors
- 6
About SynOx Therapeutics
Founded in 2020 and based in Dublin, Ireland, SynOx Therapeutics Ltd. is developing emactuzumab, a monoclonal antibody targeting CSF-1R, to treat tenosynovial giant cell tumors (TGCT) and other related diseases. SynOx Therapeutics Ltd. is developing emactuzumab, a monoclonal antibody that inhibits the CSF-1R receptor. This receptor is involved in the regulation and recruitment of macrophages, which are implicated in various pathologies, including TGCT.
Who invested in SynOx Therapeutics
6 investors across 3 rounds
See all investors in SynOx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SynOx Therapeutics
Who invested in SynOx Therapeutics?
SynOx Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SynOx Therapeutics raised?
SynOx Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SynOx Therapeutics last raise money?
SynOx Therapeutics's most recent round on record is a Series B, in Oct 2024.
What does SynOx Therapeutics do?
Founded in 2020 and based in Dublin, Ireland, SynOx Therapeutics Ltd.
Where is SynOx Therapeutics headquartered?
SynOx Therapeutics is headquartered in Dublin, Ireland.
Which VCs invest in companies like SynOx Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at SynOx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SynOx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.